KUALA LUMPUR, May 29 (Bernama) -- Claritas HealthTech and PwC announced they will collaborate on the rollout, deployment and support of a suite of medical image enhancement and artificial intelligence (AI) diagnostic software products.
“This collaboration with PwC will accelerate our global deployment strategy and deliver significant benefits to clinicians across practice areas,” said Claritas Chief Executive Officer, Chetan Baxi in a statement.
Meanwhile, PwC Global Healthcare Leader, Anthony Bruce said PwC works with national and local healthcare providers to deliver real, workable solutions to today’s challenges.
“We are always excited to work with new technologies, like Claritas, which seek to address some of the key bottlenecks in healthcare,” added Bruce.
Claritas’ image enhancement and reconstruction software, namely iRAD and iPET, both United States Food and Drug Administration (FDA)-cleared, provide modality agnostic and cost-effective solutions to alleviate the pressure on the medical imaging and diagnostic ecosystems.
iRAD can be used to enhance magnetic resonance imaging (MRI), X-Ray and computerised tomography (CT) thereby improving first time reading, reducing the need for re-scans, and improving diagnostic accuracy.
In the meantime, iPET allows accelerated PET-CT/MRI acquisition while significantly reducing the amount of contrast dosage needed.
Aims to transform the diagnostics industry with powerful and effective software products, Claritas conducts research and development in the fields of image enhancement, machine vision and AI with a focus on medical image processing and AI-assisted interpretation and diagnostics.
-- BERNAMA
No comments:
Post a Comment